MedPath

Day-case versus inpatient cochlear implantation: a randomized controlled trial.

Completed
Conditions
deafness
severe to profound bilateral sensorineural hearing loss
10019243
Registration Number
NL-OMON44709
Lead Sponsor
niversitair Medisch Centrum Utrecht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

Age >= 18 years;
Severe to profound bilateral post-lingual sensorineural hearing loss defined as >= 70 dB nHL on pure-tone audiometry in the range of 500, 1000 and 2000 Hz;
Willingness and ability to participate in all scheduled procedures outlined in the research protocol;
General health allowing general anesthesia in an outpatient setting;
Quick access to communication and transportation in case of any complications;
Good understanding of the Dutch language.

Exclusion Criteria

Severe to profound pre-lingual sensorineural hearing loss;
Severe to profound unilateral sensorineural hearing loss;
Previous cochlear implantation;
Aberrant (cochlear) anatomy on CT-scan or chronic ear infection;
General health does not allow general anesthesia in an outpatient setting;
Disability that could interfere with audiologic evaluation and/or questionnaire fulfillment.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Primary outcome measure is general quality of life measured by the Health<br /><br>Utility Index - Mark 3.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Secondary outcome measures are disease-specific quality of life, complications<br /><br>and cost-effectiveness.</p><br>
© Copyright 2025. All Rights Reserved by MedPath